drugset / Trial / NCT05003934

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

NCT05003934

NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Rheumatoid Arthritis

Timeline

Start
2021-11-07
Primary completion
2026-09
Completion
2026-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject AlloRx Cell therapy 1e+08 cells Intravenous

Indications